Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy

Pancreatic ductal adenocarcinoma (PDAC) continues to be a disease with poor outcomes and short-lived treatment responses. New information is emerging from genome sequencing identifying potential subgroups based on somatic and germline mutations. A variety of different mutations and mutational signat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pihlak, Rille, Weaver, Jamie M. J., Valle, Juan W., McNamara, Mairéad G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789367/
https://www.ncbi.nlm.nih.gov/pubmed/29329208
http://dx.doi.org/10.3390/cancers10010017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789367/
https://www.ncbi.nlm.nih.gov/pubmed/29329208
http://dx.doi.org/10.3390/cancers10010017

Ejemplares similares